TIA

TIA
Hariadhi · CC BY-SA 4.0 · source
Name	Transient ischemic attack
Caption	Perfusion diagram of cerebral ischemia
Field	Neurology
Symptoms	Sudden weakness, numbness, speech disturbance, visual loss
Complications	Stroke, recurrent ischemia
Onset	Sudden
Duration	Minutes to <24 hours (commonly <1 hour)
Causes	Embolic disease, large-artery atherosclerosis, small-vessel disease
Risks	Hypertension, atrial fibrillation, diabetes, smoking
Diagnosis	Clinical assessment, brain imaging, vascular imaging
Treatment	Antiplatelet therapy, anticoagulation if indicated, carotid intervention

TIA A transient ischemic attack is an acute neurologic event characterized by sudden focal deficits that resolve within a short interval; it is a clinical warning sign for future cerebral infarction. Patients with this condition often present to emergency departments, stroke centers, and outpatient clinics and require rapid evaluation with imaging, vascular studies, cardiac assessment, and risk-factor stratification to guide secondary prevention.

Terminology and definition

The modern definition reframes earlier time-based criteria by emphasizing tissue-based diagnosis: transient focal neurologic dysfunction caused by focal cerebral, retinal, or spinal ischemia without acute infarction on neuroimaging. Historical formulations used a 24-hour time cutoff promulgated by organizations such as the World Health Organization and debated in consensus statements from bodies like the American Heart Association and European Stroke Organisation. Distinctions are made from completed ischemic stroke and from mimics described in literature involving conditions seen by clinicians in settings such as the Mayo Clinic, Johns Hopkins Hospital, and tertiary stroke centers affiliated with institutions like Massachusetts General Hospital.

Signs and symptoms

Typical presentations mirror territorial ischemia described across case series from Harvard Medical School and multicenter registries coordinated with Centers for Disease Control and Prevention collaborations. Sudden unilateral limb weakness or numbness, transient aphasia, dysarthria, visual field deficits including monocular blindness (amaurosis fugax), and transient ataxia are frequent. Symptoms correspond to vascular territories supplied by the internal carotid artery, middle cerebral artery, posterior cerebral artery, and vertebrobasilar circulation implicated in case reports from institutions such as Stanford University School of Medicine and University College London Hospital. Differential considerations often include episodic phenomena documented by clinicians at Cleveland Clinic and Mount Sinai Health System, including migraine aura, focal seizures, hypoglycemia, and peripheral vestibulopathies.

Causes and pathophysiology

Pathophysiology centers on transient interruption of cerebral perfusion from embolic sources, in situ thrombosis with spontaneous lysis, or hemodynamic hypoperfusion. Prominent embolic sources include cardioembolism from atrial fibrillation, left ventricular thrombus post-myocardial infarction, and paradoxical embolism via a patent foramen ovale described in cohorts from tertiary centers like University of Pennsylvania Health System. Large-artery atherosclerotic plaque of the carotid artery and intracranial stenosis noted by studies at Imperial College London contribute to flow-limiting lesions. Microatheromatous disease of penetrating arteries linked to chronic hypertension and diabetes is reported in epidemiologic work by Framingham Heart Study investigators. Molecular mechanisms involve ischemia–reperfusion, excitotoxicity, inflammation, and microvascular dysfunction characterized in translational research from institutions such as NIH laboratories and university neuroscience centers.

Diagnosis and evaluation

Rapid assessment protocols used in stroke networks affiliated with American Stroke Association and regional stroke councils prioritize brain imaging and vascular/cardiac evaluation. Noncontrast computed tomography and diffusion-weighted magnetic resonance imaging performed at centers like UCLA Medical Center differentiate acute infarction from transient ischemia. Carotid duplex ultrasonography, computed tomographic angiography, and magnetic resonance angiography identify extracranial and intracranial stenoses; digital subtraction angiography is reserved for select cases at referral centers such as Karolinska University Hospital. Cardiac evaluation includes electrocardiography, prolonged ambulatory monitoring including implantable loop recorders pioneered in trials at European Society of Cardiology collaborating centers, and transthoracic or transesophageal echocardiography to detect sources described in case series from Cleveland Clinic. Risk stratification tools developed in multicenter studies, including scores validated by Oxford and other academic consortia, guide disposition.

Management and treatment

Immediate management emphasizes stabilization and secondary prevention strategies endorsed by guideline committees from National Institute for Health and Care Excellence and the American Heart Association/American Stroke Association. Antiplatelet therapy with agents studied in randomized trials led by groups at University of Oxford and McMaster University—for example, aspirin, clopidogrel, or short-term dual antiplatelet regimens—reduces early recurrence in noncardioembolic presentations. Anticoagulation is indicated for cardioembolic sources such as atrial fibrillation based on evidence from multicenter anticoagulation trials coordinated by entities like European Medicines Agency investigator networks. For symptomatic high-grade carotid stenosis, timely carotid endarterectomy or carotid artery stenting—procedures refined in trials at Cleveland Clinic and Mayo Clinic—are considered within recommended windows. Risk-factor modification encompassing antihypertensive therapy, statins supported by outcomes research at Johns Hopkins Hospital, glycemic control, smoking cessation, and lifestyle measures is integral.

Prognosis and prevention

Prognosis varies: short-term risk of ischemic stroke after a transient ischemic attack is highest within 48 hours, a finding replicated in population cohorts from Oxford Vascular Study and registries maintained by Get With The Guidelines-Stroke. Long-term outcomes depend on etiologic mechanisms, effectiveness of secondary prevention, and comorbidity burden documented in longitudinal studies by Framingham Heart Study and large healthcare systems like Kaiser Permanente. Primary prevention strategies include management of hypertension, atrial fibrillation detection and anticoagulation per European Stroke Organisation guidelines, lipid-lowering with statins per trials from National Heart, Lung, and Blood Institute, and carotid intervention for select high-risk stenoses. Public health campaigns and stroke systems of care promoted by organizations such as World Stroke Organization aim to reduce delays to presentation and improve secondary prevention uptake.

Category:Neurology